Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
36.06
Price to sales ratio
1.81

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
1058
ALKS
Alkermes plc - Ordinary Shares
47.41 USD-3.05%-1.33%-2.41%+62.86%7.95 B USD
1158
LNTH
Lantheus Holdings, Inc. - Common Stock
100.77 USD+0.30%+0.67%-1.94%+79.75%6.58 B USD
1492
INDV
Indivior Pharmaceuticals, Inc. - Common Stock
34.87 USD-1.22%-4.54%-13.50%+3.78%4.12 B USD
1795
RGC
Regencell Bioscience Holdings Limited - Ordinary Shares
5.50 USD-0.36%+3.77%-9.24%-60.46%2.72 B USD

Frequently asked questions about Amneal Pharmaceuticals, Inc. Class A Common Stock

What is the Amneal Pharmaceuticals, Inc. Class A Common Stock stock price today?

The current price of Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) is 17.54. Over the past 24 hours, the stock has changed by -2.61%. Follow the AMRX chart for real-time price dynamics.

What is the stock ticker of Amneal Pharmaceuticals, Inc. Class A Common Stock?

Amneal Pharmaceuticals, Inc. Class A Common Stock trades under the ticker AMRX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Amneal Pharmaceuticals, Inc. Class A Common Stock stock going up?

AMRX has changed by -1.79% over the last week, -4.88% over the last month, and +66.26% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Amneal Pharmaceuticals, Inc. Class A Common Stock?

Amneal Pharmaceuticals, Inc. Class A Common Stock currently has a market capitalization of 5.6 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Amneal Pharmaceuticals, Inc. Class A Common Stock earnings last quarter?

Last quarter, Amneal Pharmaceuticals, Inc. Class A Common Stock reported earnings of 0.18 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Amneal Pharmaceuticals, Inc. Class A Common Stock revenue for the last quarter?

Amneal Pharmaceuticals, Inc. Class A Common Stock reported quarterly revenue of 796.2 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Amneal Pharmaceuticals, Inc. Class A Common Stock net income for the last quarter?

Amneal Pharmaceuticals, Inc. Class A Common Stock reported net income of 57.66 M for the last quarter. The previous quarter showed 62.26 M, which means net income changed by -7.38%.

How many employees does Amneal Pharmaceuticals, Inc. Class A Common Stock have?

As of the latest available data, Amneal Pharmaceuticals, Inc. Class A Common Stock has 8 500 employees. Workforce size can provide additional context about the company's scale and operations.

What is Amneal Pharmaceuticals, Inc. Class A Common Stock EBITDA?

Amneal Pharmaceuticals, Inc. Class A Common Stock EBITDA is 134.62 M, and its EBITDA margin is 16.91%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Amneal Pharmaceuticals, Inc. Class A Common Stock stock?

You can buy Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Amneal Pharmaceuticals, Inc. Class A Common Stock stock?

Investing in Amneal Pharmaceuticals, Inc. Class A Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the AMRX chart and related analysis on metatrader.com as part of your research.

Amneal Pharmaceuticals, Inc. - Class A Common Stock

Amneal Pharmaceuticals, Inc. is an American publicly traded pharmaceutical company that develops, manufactures and distributes generics and specialty pharmaceutical products. The company is headquartered in Bridgewater, New Jersey, and is one of the largest manufacturers of generic drugs in the United States.

News